本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ArTara Therapeutics, Inc.

3.86
-0.0500-1.28%
成交量:29.57萬
成交額:113.70萬
市值:2.28億
市盈率:-2.85
高:3.94
開:3.91
低:3.80
收:3.91
52周最高:7.82
52周最低:3.02
股本:5,909.55萬
流通股本:5,741.44萬
量比:0.84
換手率:0.52%
股息:- -
股息率:- -
每股收益(TTM):-1.3535
每股收益(LYR):-1.3409
淨資產收益率:-45.80%
總資產收益率:-28.82%
市淨率:1.41
市盈率(LYR):-2.88

資料載入中...

2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/07/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/29

重要事件披露

Form 8-K - Current report
2026/06/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/16

重要事件披露

Form 8-K - Current report
2026/05/20

SEC問詢函

Form CORRESP - Correspondence
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/10

重要事件披露

Form 8-K - Current report
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities